United States · FDA National Drug Code directory
Omvoh
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0002-8870_3553ca93-cbe0-4286-b806-a423598eb42a
- Product NDC
- 0002-8870
- Form
- INJECTION, SOLUTION
- Composition / generic term
- mirikizumab-mrkz
- Labeler
- Eli Lilly and Company
- Marketing category
- BLA
- Marketing start / end (source format)
- 20240429
- Source listing expiry
- 20271231
Source-listed ingredients
- MIRIKIZUMAB — 100 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 SYRINGE in 1 CARTON (0002-8870-27) / 1 mL in 1 SYRINGE (0002-8870-01) · 0002-8870-27
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →